BioCentury
ARTICLE | Distillery Therapeutics

Cancer

August 9, 2017 6:42 PM UTC

Cell culture and mouse studies suggest inhibiting CDCP1 could help treat metastatic triple-negative breast cancer (TNBC). In three human TNBC cell lines, CDCP1 knockdown increased numbers of cytoplasm...